WWiKY’s mission and the vision are to provide cutting-edge safe and effective precision medicine for hypoxic cancerous tumors (found in ALL types of cancer) by combining the powers of therapy and diagnostic (theranostic) technologies and make the business and science globally accessible. WWiKY owns several national and international patents related to the products and technologies to accomplish this mission.

Solid hypoxic tumors are therapy-resistant, metastatic and their effective treatment is yet an unmet medical need. WWiKY is actively engaged in delivering theranostic solutions for cancer management that emanate from an academic environment that is closely associated with active health care delivery. In this environment, medical oncology clinicians, health care
professionals and discovery scientists work together to enhance our understanding of cancer, and to develop precision preventative and combative anti-cancer strategies. Integration of scientific discovery and translational clinical research forms the core of WWiKY’s personalized cancer management vision.